Market closed

Maravai LifeSciences/$MRVI

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Maravai LifeSciences

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Ticker

$MRVI
Trading on

Industry

Life Sciences Tools & Services

Employees

580

MRVI Metrics

BasicAdvanced
$684M
Market cap
-
P/E ratio
-$1.66
EPS
0.02
Beta
-
Dividend rate
$684M
0.02
$11.56
$4.28
2.1M
10.738
9.599
97.839
79.237
-0.88%
-1.61%
-42.93%
2.358
1.98
-23.94
-55.743
-33.99%
-989.67%
-25.48%
-29.34%

What the Analysts think about MRVI

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Maravai LifeSciences stock.

MRVI Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MRVI Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MRVI

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Maravai LifeSciences stock?

Maravai LifeSciences (MRVI) has a market cap of $684M as of November 22, 2024.

What is the P/E ratio for Maravai LifeSciences stock?

The price to earnings (P/E) ratio for Maravai LifeSciences (MRVI) stock is 0 as of November 22, 2024.

Does Maravai LifeSciences stock pay dividends?

No, Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next Maravai LifeSciences dividend payment date?

Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders.

What is the beta indicator for Maravai LifeSciences?

Maravai LifeSciences (MRVI) has a beta rating of 0.02. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.